Glycogen Storage Disease Type 14

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2019-01-25
Clinical Trial Update: Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14 [Phase 1, Phase 2]
A clinical trial update on ORL-1G (D-galactose) for glycogen storage disease type 14, currently in Phase 1/2 with status unknown.